Tudóstér: Domán Marianna publikációi

Jakab, S., Bálint, Á., Cseri, K., Bali, K., Kaszab, E., Domán, M., Halas, M., Szarka, K., Bányai, K.: Genome stability assessment of PRRS vaccine strain with new ARTIC-style sequencing protocol.
Front. Vet. Sci. 10 1-8, 2024.

Domán, M., Kaszab, E., Laczkó, L., Bali, K., Makrai, L., Kovács, R., Majoros, L., Bányai, K.: Genomic epidemiology of antifungal resistance in human and avian isolates of Candida albicans: a pilot study from the One Health perspective.
Front. Vet. Sci. 11 1-7, 2024.

Kaszab, E., Bali, K., Marton, S., Ursu, K., Farkas, S., Fehér, E., Domán, M., Martella, V., Bányai, K.: Metagenomic Identification of Novel Eukaryotic Viruses with Small DNA Genomes in Pheasants.
Animals (Basel). 14 (2), 237,, 2024.

Gál, B., Varga-Kugler, R., Ihász, K., Kaszab, E., Domán, M., Farkas, S., Bányai, K.: Marked Genotype Diversity among Reoviruses Isolated from Chicken in Selected East-Central European Countries.
Animals (Basel). 13 (13), 1-13, 2023.

Domán, M., Makrai, L., Lengyel, G., Kovács, R., Majoros, L., Bányai, K.: Molecular Diversity and Genetic Relatedness of Candida albicans Isolates from Birds in Hungary.
Mycopathologia. 186 (2), 237-244, 2021.

Kovács, R., Bozó, A., Gesztelyi, R., Domán, M., Kardos, G., Nagy, F., Tóth, Z., Majoros, L.: Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Int. J. Antimicrob. Agents. 47 (4), 304-310, 2016.

Domán, M., Kovács, R., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., Kardos, T., Saleh, Q., Majoros, L.: Killing rates of caspofungin in 50 percent serum correlate with caspofungin efficacy against Candida albicans in a neutropenic murine model.
Current Drug Del. 13 (2), 255-264, 2016.

Bozó, A., Domán, M., Majoros, L., Kardos, G., Varga, I., Kovács, R.: The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
J. Microbiol. 54 (11), 753-760, 2016.

Domán, M., Kovács, R., Perlin, D., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., Majoros, L.: Dose escalation studies with caspofungin against Candida glabrata.
J. Med. Microbiol. 64 (9), 998-1007, 2015.

Kovács, R., Bozó, A., Domán, M., Nagy, F., Tóth, Z., Majoros, L.: Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Mycoses. 58 79-80, 2015.

Berényi, R., Kovács, R., Domán, M., Gesztelyi, R., Kardos, G., Juhász, B., Perlin, D., Majoros, L.: Efficacy of single large doses of caspofungin in a neutropenic murine model against the "psilosis" group.
New Microbiol. 37 (3), 355-362, 2014.

Kovács, R., Gesztelyi, R., Berényi, R., Domán, M., Kardos, G., Juhász, B., Majoros, L.: Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua.
J. Med. Microbiol. 63 (2), 186-194, 2014.

Kovács, R., Gesztelyi, R., Perlin, D., Kardos, G., Domán, M., Berényi, R., Majoros, L.: Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.
Mycopathologia. 178 (3-4), 197-206, 2014.

Majoros, L., Kovács, R., Berényi, R., Domán, M., Miszti, C., Kardos, G.: Effect of 50% human serum on he killing activity of micafungin against C. dubliniensis, C. lusitaniae, C. guilliermondii and C. kefyr using time-kill methodology.
Mycoses. 56 64-65, 2013.

Kovács, R., Gesztelyi, R., Berényi, R., Domán, M., Kardos, G., Juhász, B., Majoros, L.: Should echinocandin doses be increased against Candida species? An in vitro and in vivo study of caspofungin against Candida albicans, C. krusei and C. inconspicua.
Mycoses. 56 (Suppl.), 60, 2013.